MK-0517

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0517, covering 2013-12-12 to 2013-12-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012) [Phase 1]